Global Heparin Market Growth Forecast Analysis By Manufacturers - Reddy’s Laboratories Ltd., Fresenius SE & Co KGaA

1
Global Heparin Market Growth is set to be driven
by the Increasing Geriatric Population
2

• Heparin is an injectable anticoagulant
  prescription medicine used to treat and prevent
  the symptoms of blood clots caused by medical
  conditions or medical procedures. Additionally,
  it is utilized to make an anti-clotting surface
  inside a variety of medical devices, including
  test tubes and renal dialysis machines.
• The Global Heparin Market is expected to grow at
  a rate of 5 by 2026. The rising prevalence of
  chronic diseases such as venous thromboembolism,
  pulmonary embolism, renal diseases, and
  cardiovascular disorders, increasing geriatric
  population, high demand for anticoagulants,
  growing application of heparin in various
  surgeries such as orthopedic and heart surgeries,
  and the expanding availability of synthetic and
  semi-synthetic heparin mimetics that help in the
  treatment of cancer, coagulation, and
  inflammatory diseases are a few of the main
  factors driving the global heparin market.
• Increasing Usage of Heparin in Various
  Applications Drives the Heparin Market
• Anticoagulants work by decreasing the clotting
  ability of the blood. It helps to prevent the
  formation of clots as well as stop the further
  expansion of any existing clots. As a result, it
  may be used in a variety of applications,
  including
• Prevent or treat certain blood vessel, heart, and
  lung conditions
• Prevent blood clotting during open-heart surgery,
  bypass surgery, kidney dialysis, and blood
  transfusions
• Prevention of deep vein thrombosis
• Prevention of a blood clot following percutaneous
  coronary intervention

3
Growing Adoption of Low Molecular Weight
Unfractionated Heparin Over Heparin to Prevent
Deep Vein Thrombosis or Pulmonary Embolism Fuels
the Demand Low-molecular-weight heparins have
several advantages over UFH that have led to
their increasing use for several thromboembolic
indications such as deep vein thrombosis (DVT)
and pulmonary embolism (PE) as well as atrial
fibrillation (AF). In comparison to heparin, LMWH
provides better bioavailability and a longer
half-life, streamlined dose, predictable
anticoagulant response, a reduced risk of
heparin-induced thrombocytopenia (HIT), and a
reduced risk of osteoporosis. Explore Premium
Report on Heparin Market _at_ https//meditechinsight
s.com/global-heparin-market/ The Potential Role
of Heparin in Covid-19 Patients Boosts the
Heparin Market Growth Many patients with COVID-19
develop a clinically significant coagulopathy.
COVID-19 infections can lead to an increased risk
of blood clots. These blood clots can lead to
individuals being admitted to hospital, or,
unfortunately in severe cases, death. Similarly,
patients with COVID-19 are at high risk for
developing clinically significant large-vessel
thrombosis. Thus, early usage of anticoagulation
may reduce the risk of coagulopathy,
microthrombus formation, and organ damage. Key
Challenges/ Constraints Heparin Market The main
factors limiting the market's growth are the side
effects associated to the usage of heparin drugs
and the availability of another anticoagulant on
the market.
4

• North America Holds the Largest Market Share but
  APAC is Set to Witness Strongest Growth
• North America holds the largest market share of
  the heparin market followed by Europe and the
  Asia Pacific. This can be primarily attributed to
  the high burden of chronic diseases, the presence
  of advanced and robust healthcare infrastructure,
  increasing demand for heparin in various
  surgeries, and rising incidences of
  cardiovascular disorders in the region.
• Companies Adopt both Organic Inorganic Growth
  Strategies to Increase their Market Share
• Players operating in the heparin market are
  adopting organic and inorganic growth strategies
  such as collaborations, acquisitions, and
  expansions to garner market share.
• For instance,
• In February 2022, Techdow USA Inc. announced the
  launch of its Heparin Sodium Injection, USP in
  the United States market
• In January 2022, Ohio-based biotechnology
  company Optimvia Pharmaceuticals announced the
  development of a synthetic method for creating
  large quantities of heparin, which is used to
  make a common blood thinner at a reasonable price

5
Competitive Landscape Analysis of Heparin
Market The global heparin market is marked by the
presence of established key players such as
Baxter International Inc., B. Braun Holding GmbH
Co. KG, Dr. Reddys Laboratories Ltd., and
Fresenius SE Co KGaA among others. For More
Detailed Insights, Contact Us _at_ https//meditechin
sights.com/contact-us/ About Medi-Tech
Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com